H2375: Relative to menstrual product ingredient disclosure

Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.

Enable full analysis features for your organization.

Or email us directly at sales@legiequity.us.